Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -7.24% is 71% above its 5-year average of -25.34%, near the high end of its 5-year range (-39.28%–-7.24%).
26.76% above its 12-month average of -9.89%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -2.52%.
RETURN ON ASSETS (ROA)
-7.24%
RETURN ON ASSETS (ROA) AVG TTM
-9.89%
RETURN ON ASSETS (ROA) AVG 3Y
-22.30%
RETURN ON ASSETS (ROA) AVG 5Y
-25.34%
RETURN ON ASSETS (ROA) AVG 10Y
-32.43%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.76%
CURRENT VS 3Y AVG
+67.54%
CURRENT VS 5Y AVG
+71.42%
CURRENT VS 10Y AVG
+77.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-246.56%
vs the sector median at left
Natera, Inc.
Market Cap
$58.77B
Return on Assets (ROA)
-7.24%
TTM Avg
-9.89%
3Y Avg
-22.30%
5Y Avg
-25.34%
Market Cap
$60.13B
Return on Assets (ROA)
3.13%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$63.32B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$53.47B
Return on Assets (ROA)
2.99%
TTM Avg
2.96%
3Y Avg
2.15%
5Y Avg
1.30%
Market Cap
$49.03B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$48.72B
Return on Assets (ROA)
1.85%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$47.38B
Return on Assets (ROA)
10.31%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$71.48B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.77B | -7.24% | -9.89% | -22.30% | -25.34% |
| Cencora, Inc. (COR)vs › | $60.13B | 3.13% | 2.14% | 2.52% | 0.85% |
| Boston Scientific Corporation (BSX)vs › | $63.32B | 8.11% | 5.66% | 4.50% | 3.49% |
| Cardinal Health, Inc. (CAH)vs › | $53.47B | 2.99% | 2.96% | 2.15% | 1.30% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 7.25% | 19.91% | 18.29% | 17.04% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 1.85% | 3.00% | 3.04% | 2.95% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 10.31% | 10.56% | 11.14% | 10.55% |
| Humana Inc. (HUM)vs › | $46.63B | 2.23% | 2.52% | 4.20% | 5.49% |
| Cigna Corporation (CI)vs › | $71.48B | 4.08% | 2.99% | 3.50% | 3.82% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 1.77% | -0.35% | -1.89% | -2.43% |
ROA
-7.2%
ROE
-10.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -8.30% |
| 2024-12-31 | -11.47% |
| 2023-12-31 | -30.16% |
| 2022-12-31 | -39.28% |
| 2021-12-31 | -38.15% |
| 2020-12-31 | -24.65% |
| 2019-12-31 | -21.42% |
| 2018-12-31 | -47.79% |
| 2017-12-31 | -63.52% |
| 2016-12-31 | -45.46% |
| 2015-12-31 | -26.49% |
| 2014-12-31 | -4.17% |
| 2013-12-31 | -62.14% |
| 2012-12-31 | -573.02% |
